| abstract |
The invention relates to a nicotinamide adenine dinucleotide (NAD) precursor for use in the treatment and/or prevention of an age-related medical condition in a subject, wherein said NAD precursor is administered in combination with a calorie restriction diet (CRD) and/or a calorie restriction mimetic (CRM). Furthermore, the invention also relates to a pharmaceutical combination comprising a NAD precursor and a CRM. |